Marquette University

e-Publications@Marquette
College of Nursing Faculty Research and
Publications

Nursing, College of

8-1-2009

Current Medical Research Winter 2007/Spring
2008
Richard Fehring
Marquette University, richard.fehring@marquette.edu

Accepted version. The Linacre Quarterly, Vol. 76, No. 3 (August 1, 2009): 315-346. DOI. © 2009
Catholic Medical Association. Used with permission.

Marquette University

e‐Publications@Marquette
College of Nursing Faculty Research and Publications/Department of
Nursing
This paper is NOT THE PUBLISHED VERSION; but the author’s final, peer‐reviewed manuscript. The
published version may be accessed by following the link in the citation below.

The Linacre Quarterly, Vol. 76, No. 3 (2009): 315‐346. DOI. This article is © Catholic Medical Association
and permission has been granted for this version to appear in e‐Publications@Marquette. Catholic
Medical Association does not grant permission for this article to be further copied/distributed or
hosted elsewhere without the express permission from Catholic Medical Association.

Current Medical Research Winter 2007/Spring
2008
Richard Fehring
College of Nursing, Marquette University, Milwaukee WI

End‐Expiratory CO2 Pressure as a Measure for the Beginning of the Fertile Phase of the
Menstrual Cycle
There are few self‐detected natural biological indicators for estimating the beginning of the fertile
phase of the menstrual cycle for use in natural family planning. The current measures include the first
observation or sensation of cervical mucus, the self‐measure of the estrogen rise in the urine with an
electronic fertility monitor, and/or some type of calendar based formula. However, it has been known
for many years that a woman's respiration changes during the phases of the menstrual cycle. A
research team from Austria and Germany used this knowledge to determine if a woman's end‐
expiratory carbon dioxide (CO2) pressure levels could be used as a self‐measure for the beginning of
the fertile phase (D. Hadziomerovic, K.T. Moeller, P. Lict, A. Hein, S. Veitenhansel, M. Kusmitsch, and L.
Wildt, “The Biphasic Pattern of End‐Expiratory Carbon Dioxide Pressure: A Method for Identification of
the Fertile Phase of the Menstrual Cycle,” Fertility and Sterility 90 [2007] 731–736). If the CO2 end‐
pressure was effective in estimating the fertile phase, the researchers intended to develop a simple
instrument for self‐measuring end‐tidal carbon dioxide production.

The participants for this study were 160 women (18–48 years old) with a history of regular menstrual
cycles between 24–32 days in length. They produced 195 menstrual cycles in which end‐expiratory
pressure levels were measured once daily. Serum levels of estrogen, progesterone, and luteinizing
hormone (LH) were measured from day 10 of the menstrual cycle until the LH surge was observed.
Partial pressure of CO2 was measured by an infrared spectrometry device that was connected to a side
stream end‐expiratory air collection device (i.e., a capnometer). An ovulatory cycle for this study was
defined as a rise in serum levels of estrogen followed by an LH surge or progesterone levels above 10
ng/ML. Of the 195 menstrual cycles, 150 were ovulatory.
The theory behind the carbon‐dioxide levels as a measure of the beginning of the fertile phase is that
the human respiratory center is sensitive to increases in estrogen or progesterone. The researchers
found that there was a significant mean decrease in carbon dioxide levels (i.e., 5–9 mm Hg) about 1–5
days before the LH surge. They did not find a significant decrease in carbon dioxide pressure levels in
the non‐ovulatory cycles. They also discovered that administering estrogen or progesterone alone to
women who had chemically suppressed ovaries also showed a decrease in carbon dioxide pressure.
The authors concluded that a capnometer might be used in natural family planning as a means of
estimating the beginning of the fertile phase along with another measure such as the urinary LH surge
to estimate ovulation. They also indicated that a simple self‐measure capnometer device has yet to be
perfected.
Comments: Obviously measures of end‐expiratory carbon dioxide as a marker for the beginning of the
fertile phase is exploratory at this time. However, the Austrian/German researcher team did find that
there was no circadian rhythm aspects to that measure—i.e., the measure could be taken any time
during the day—unlike urinary LH and basal body temperature. If a simple, accurate, and easy to use
capnometer could be developed, this would be another tool to be used in NFP. The capnometer
monitor—unlike measures of urinary estrogen and LH—would not require the use of expensive test
strips.

Method Discontinuation Due to Dissatisfaction Found to Be Low among Fertility
Awareness Users Compared to Users of Hormonal Contraceptives
Unintended pregnancies are a major health problem in the United States. Approximately 50% of all
pregnancies in the U.S. are unintended, and many of these pregnancies are aborted. Most of these
unintended pregnancies are due to discontinuation of contraceptive methods; and, in turn,
discontinuation is often due to dissatisfaction with use of these methods. Researchers from the Office
of Population Research at Princeton University, therefore, sought to determine the reasons for (and
percentage of) discontinuations among U.S. women using reversible methods of contraception (C.
Moreau, K. Cleland, and J. Trussell, “Contraceptive Discontinuation Attributed to Method
Dissatisfaction in the United States,” Contraception 76 [2007]: 172–173).
The Princeton researchers utilized the Cycle 6 (2002) data set from the National Survey of Family
Growth (NSFG). This data set involved 7,643 women participants between 15–44 years of age. The
NSFG is a periodic national population‐based survey of U.S. women selected through probability
statistical methods to obtain representative samples. The women are interviewed in person about
their contraceptive and reproductive history with an average of 85 minutes per interview. The NSFG
had an 80% response rate. Of the 7,643 women, 6,724 used a reversible method of contraception

sometime during their reproductive life span. Of these women, 33% used fewer than 3 different
reversible methods, 50% used 3–4 different methods, and the remaining 17% used more than 4
methods.
The researchers found that users of the cervical cap and diaphragm had the highest (un‐weighted)
percentage (51.6%) of discontinuation due to dissatisfaction, with users of the sponge in second place
at 47.6%. Users of the long acting contraceptives DepoProvera and Norplant had a 42% discontinuation
rate due to dissatisfaction, and users of oral contraceptives were associated with a 29% risk of
discontinuation. However, users of fertility awareness methods had only a 14.6% discontinuation risk.
The lowest rate of discontinuation (11%) was among users of the male condom. Among the users of
the Pill, Norplant, and Depo‐Provera, the most frequent reasons for discontinuation were side effects,
menstrual cycle disorders, and method failure.
The most frequent reasons that women provided for discontinuation of the male condom included
partner dissatisfaction, decreased sexual pleasure, and messiness of use. The authors suggested better
contraceptive counseling might help improve satisfaction and continuation. However, the counseling
should be based on a better understanding as to why women discontinue contraceptive methods.
Comments: No matter how the contraceptive method is packaged and marketed and how women are
counseled on why they should not discontinue a method of contraception, if the method causes
discomforting side effects, menstrual cycle disorders, is messy to use, or interferes with sexual
pleasure, there will still be high rates of discontinuation. The “ever use” percentage of fertility
awareness users listed in this study was 17.9%, compared with 84.5% ever users of the pill and 57.5%
users of withdrawal. Fertility awareness was not defined, but probably included self‐devised calendar
methods and the more modern mucus‐ and temperature‐based methods. It would be of benefit to
understand better why users of fertility awareness methods discontinue their use.

Method Failure Most Frequent Reason for Discontinuing Periodic Abstinence Methods
among Brazilian Women
Researchers utilized a 1996 population‐based data set of 12,612 Brazilian women between the ages of
15–49 (selected through a 2‐stage, random‐selection method) to analyze reasons for contraceptive
dissatisfaction (I.C. Leite and N. Gupta, “Assessing Regional Differences in Contraceptive
Discontinuation, Failure and Switching in Brazil,”Reproductive Health 4 [2007]). The data set contained
variables on contraceptive use and discontinuation ascertained through retrospective survey methods.
Researchers were interested in reasons for discontinuation of reversible methods of contraception and
expressed a concern about the high rate of unintended pregnancy in that country. Furthermore,
unintended pregnancy tended to occur during the time period of discontinuing and switching to
another method of contraception. Greater than 50% of the women who use contraceptive methods in
Brazil use sterilization (either female 49% or male 3%) as a method of family planning. Only 4% of
Brazilian women list periodic abstinence as a method of family planning.
The researcher found that “method failure” was the most frequent reason (17%) why women
discontinue periodic abstinence methods in Brazil. The most frequent reason given for abandoning use
of the Pill (11.8%) and injectable hormones (27.4%) was because of side effects and health. The most
frequent reason for discontinuing the condom (5.1%) was method failure. The researchers calculated a

12‐month cumulative failure rate for the various contraceptive methods and found a 22.7% failure rate
for traditional methods (that included periodic abstinence and withdrawal), a 6.5% failure rate for the
Pill, and 9.1% for the condom. However, the abandonment rate for the Pill was 13.4% and for
injectable contraception 17%, whereas for the traditional methods only 3.7%. The highest continuation
rate was found among Pill users at 64%, followed by condom users at 46%, and then traditional
methods at 44%. There was a greater rate of abandonment, switching, and failure rates among the less
educated younger women. The researchers felt there was a need for increased access to a greater
range of contraceptive methods.
Comments: Since the fertility rate (2.1) among the more wealthy and educated Brazilian women is
much lower than among the poor and less educated, and since the failure rates are also lower among
the more educated, maybe the Brazilian government would do better to concentrate its efforts on
better education and economic opportunities for the poor. Perhaps more efforts should be made to
increase access to a greater variety of choices of modern fertility awareness based methods, especially
for the poor that cannot afford the Pill or injectables.

Study Finds 7.7% Failure Rate among French Fertility Awareness Users
French researchers recently conducted a retrospective population‐based study to determine method‐
specific contraceptive failure rates among women participants in a French national database (C.
Moreau, J. Trussell, G. Rodriquez, N. Bajos, and J. Bouyer, “Contraceptive Failure in France: Results
from a Population‐Based Survey,” Human Reproduction 22 [2007]: 2422–2427). A stimulus for the
study was the concern that 1 of 3 pregnancies among French women is unintended, and, of these, 65%
occur while on some form of contraception. The database was from the population‐based cohort 2000
Cocon Study. This study involved a representative sample of 1,689 women aged 18–44 years who were
randomly selected to answer a series of questions on their contraceptive and reproductive history, i.e.,
the time from first intercourse to the date of the interview. The sample was over‐represented by
women who had had an abortion or an unintended pregnancy. Life table survival analysis (Kaplan‐
Meier) was used for data analysis.
The researchers discovered that the lowest first year failure rate of 1.1% was among IUD users,
followed by a 2.4% failure rate among oral hormonal contraceptive pill users, then the male condom at
3.3%, 7.7% among fertility‐awareness users, 10.1% among withdrawal users, and 21.7% among those
using spermicides. They also found a 24‐month failure rate of 4.3% among IUD users, 3.6% among Pill
users, 7.8% with condom users, and 18.8% among fertility awareness users. The researchers
mentioned that the contraceptive failure rates among French women are in the same order of
effectiveness but significantly lower than those among U.S. women. They speculated on possible
reasons for this difference, including underreporting of abortion and the fact that the U.S. data analysis
includes all pregnancies regardless of intention. Furthermore, the French data set could be limited by
recall bias and lack of data on sexual activity. The researchers concluded that comparative
contraceptive failure rates between French and U.S. women suggest differences in contraceptive
practices. They recommended further study of contraceptive failure rates and practices among
different populations.
Comments: The “unintended” label given by the researchers to pregnancies was rather liberal since it
included: a) not being planned at all, b) being planned later, and c) did not remember if she had

planned to become pregnant at that time. The types of fertility awareness methods listed in the study
included 31.6% using “periodic abstinence” and 68.4% “safe period by temperature or Ogino.” This is
confusing in that it is not clear what they mean by “periodic abstinence” other than maybe this was a
self‐determined guess by the woman of when she was fertile or not. Furthermore, it is surprising that
there was not an inclusion of more modern fertility awareness methods, such as the ovulation method
and/or the symptothermal methods. Another point to consider is whether this retrospective cohort
population of women contraceptive users was representative of the entire female reproductive
population, i.e., the authors did not attempt to insure or provide evidence for representation of their
sample of women. Finally, it is worth noting that there is a need for population‐based studies which
delineate more specifically which NFP methods were used and their comparative effectiveness, as well
as perhaps a need for more effective methods of NFP.

Use of Passive Lactation Amenorrhea Method Related to Low Empowerment among
Egyptian Women
Empowering women to make decisions about family planning and other health behaviors is important
for the health of the woman and her family. An Egyptian researcher was interested in the association
of the lactation amenorrhea method (LAM) and passive LAM on the empowerment of household
decisions among Egyptian women with children below 6 months of age (M. Afifi, “Lactational
Amenorrhea Method for Family Planning and Women Empowerment in Egypt,” Singapore Medical
Journal 48 [2007]: 758–762). Passive LAM was defined as women who: a) satisfied all elements of LAM,
b) did not report the use of another method of family planning, and c) did not report relying on
prolonged breastfeeding as a method of family planning.
The author obtained data from the 2000 Egypt Demographic Health Survey which included 15,773
never married women. From that data set she selected women whose last born was less than three
years of age, were currently married, were not sterilized, and were currently breastfeeding their
children. There were 3,447 women who met those criteria, and, of these, 1,141 had children less than
six months of age.
The researcher found that nearly 58% of the sample had children under six months of age and were
exclusive breast‐feeders, and, of these women, 70% had amenorrhea, i.e., they met the LAM criteria
of: a) full or near full breastfeeding, b) post‐partum amenorrhea, and c) an infant under 6 months of
age. Most of the women (82%) who met the LAM criteria were passive LAM users. Almost 12% of the
LAM users also used another method of contraception. The most frequent method among the entire
sample was the IUD (33%). The researchers also found that empowerment in household decision
making inversely predicted passive LAM along with increase in child age, i.e., the less empowered, the
greater use of passive LAM. They concluded that women who had a low empowerment index in
household decisions were more likely to use passive LAM. The passive use of LAM, however, might
lead to discontinuation and unnecessary use of contraceptives. They felt that if women were provided
knowledge of LAM, they would be more likely continue to use LAM and progress to use modern
methods of contraception.
Comments: It should be added that increasing the knowledge of natural family planning and fertility
awareness methods might empower the woman and her spouse. This type of empowerment might
result in not needing to use hormonal or IUD methods of contraception. A recent study of LAM among

1,490 Mexican women found that the main reasons for accepting the use of LAM were “conviction
following postpartum counseling” and “use of LAM initially before switching to another method of
contraception” (M.G. Lopez‐Martinez, G. Romero‐Gutierrez, and A.L. De Leon, “Acceptance of
Lactational Amenorrhea for Family Planning after Postpartum Counseling,” European Journal of
Contraception and Reproductive Health Care 11 (2006): 297–301).

Fertility
Consuming Multivitamins (at Least Three per Week) Associated with Reduced Risk of
Ovulatory Infertility
Infertility occurs among 1 of 6 couples over a reproductive lifetime, especially among couples in
developed countries that are delaying childbearing to later in life. Use of IVF for treating infertility is
extremely expensive and time consuming. Therefore, less expensive and less invasive methods of
treatment or prevention are important. There is some evidence that the use of folate supplements aids
in the ovarian response to FSH. Therefore, Harvard University researchers sought to determine the
association of multivitamin supplementation on the incidence of ovulatory infertility (J.E. Chavarro,
J.W. Rich‐Edwards, B.A. Rosner, and W.C. Willett, “Use of Multivitamins, Intake of B Vitamins, and Risk
of Ovulatory Infertility,” Fertility and Sterility 89 [2008]: 668–676).
The participants for this study were a subset of the Nurses’ Health Study (NHS) that began in 1989 with
116,671 female United States registered nurses between the ages of 24 to 42 years who were followed
with a mailed questionnaire every 2 years. The questionnaire included information on dietary patterns,
vitamin use, whether the respondents were unsuccessful in achieving pregnancy, and what caused the
inability to conceive. The researchers identified 18,555 women without a history of infertility who tried
to become pregnant or who became pregnant during the 8‐year follow‐up period of the study. In the 8‐
year follow‐up period women who reported infertility caused by an ovulatory disorder were
considered cases, and the remaining women were considered non‐cases.
The researchers discovered that during the 8‐year follow‐up period of the NHS, there were 26,971
pregnancies and pregnancy attempts among 18,555 women. Of these pregnancy attempts, 3,430
reported infertility from any cause, and, of these, 438 reported ovulatory infertility. When adjusted for
age and calendar time, multivitamin users had approximately a 1/3 lower risk of developing ovulatory
infertility than nonusers (p < 0.001). The association of multivitamin use was dose dependent in that
there was no difference in risk of infertility with those that consumed 2 or less multivitamins per week.
The researchers estimated that 20% of ovulatory infertility could be avoided if women consumed 3 or
more multivitamins per week. Specifically, the intake of folic acid, iron, vitamins B1, B2, and D
attenuated the inverse association between multivitamins and ovulatory infertility. Furthermore, there
was a strong inverse association between folic acid intake and ovulatory infertility. There was no
interaction between use of multivitamins and age or presence of long menstrual cycles. However,
multivitamin users were more likely to consume less alcohol and coffee, to smoke less, and to be
physically active compared with nonusers of multivitamins. The authors concluded that the
consumption of multivitamins at least 3 times per week was associated with a reduced risk of
ovulatory infertility and that this association appeared to be partially mediated by folic acid.

Comments: NFP and fertility awareness method (FAM) teachers should recommend multivitamins that
contain folic acid for those women who wish to attempt a pregnancy, particularly for those women
who have long and irregular cycle patterns. Folic acid supplementation is already recommended for
women wishing to become pregnant to prevent tubal defects. Therefore, the added effect of
decreasing ovulatory infertility is a plus.

Supplementary Feeding Related to Resumption of Menstruation and Ovulation
The time after delivery of a child and before the onset of menstrual cycles is a difficult time for women
(who wish to avoid pregnancy) because of the variability of return of menstruation and ovulation. The
return of menstruation does not mean the return of ovulation. Furthermore, breastfeeding and
supplementary feeding patterns confound this variability. Therefore, Chinese researchers studied the
relationship of supplementary feeding after child birth to the return of menstruation and ovulation (W.
Li and Y. Qiu, “Relation of Supplementary Feeding to Resumption of Menstruation and Ovulation in
Lactating Postpartum Women,” Chinese Medical Journal 120 [2007]:868–870).
The participants for this study were 101 primiparous lactating women from one province in China. Each
participant monitored her basal body temperature every morning along with cervical mucus
observations and completed a lactation history questionnaire. The participants were also monitored by
ultrasonography, beginning at 6 weeks postpartum, to determine follicular development and to
document ovulation.
Of these 101 women, 53 had ovarian follicules larger than 1.8 cm in diameter at the first measurement.
The Chinese researchers found that those women with larger follicules (i.e., over 1.8 cm) began
supplementary feeding earlier (a mean of 4 months; + 1.1 months). The first ovulation occurred at 110
days past delivery (mean 155; + 45 days), and the BBT was elevated 6–13 days afterwards. Of the 53
women, 23 (43.4%) had their first ovulation before their first menses. The other 30 had their first
ovulation 8–172 days after the first documented menses—14 of which had their first ovulation after
their second recorded menses and 3 after the third menses. They also found that the start of
supplementary feeding positively correlated with the resumption of ovulation (r=0.476, p<0.01) and
menstruation (r=0.555, p<0.01). The rate of ovulation within the first 6 months post‐delivery was 1–5%
among total breastfeeding mothers. The authors concluded that the starting time of supplementary
feeding significantly affected the resumption of menstruation and ovulation. However, many other
factors affect the resumption of menstrual cycles. They recommended that women prolong
breastfeeding and postpone supplementary feeding to lengthen the time of amenorrhea.
Comments: I found it remarkable that the BBT shift (that confirmed ovulation) was 6–13 days after the
ultrasound documented ovulation. Furthermore, ovulation occurred before the first menses in a
considerable number of cases. This would negate the use of the BBT shift and menses as a viable
marker for the return of ovulation and the resumption of intercourse.

Men with Excess Body Weight Are at Increased Risk for Infertility
Researchers from the National Institute of Environmental Health Sciences (NIEHS) recently investigated
the influence of male obesity on infertility (R.H.N. Nguyen, A.J. Wilcox, R. Skjaervben, and D.D. Baird,
“Men's Body Mass Index and Infertility,” Human Reproduction 22 [2007]: 2488–2493). Obesity in the

United States (and worldwide) is increasing and is a risk related to many health problems. There have
been few population‐based studies to determine the influence of body mass and infertility among
males, and there are no studies that examined coital frequency as a confounding factor. Therefore,
NIEHS scientists conducted a study to determine the influence of being overweight, i.e., having a body
mass index (BMI) of 25 or over, in association with infertility that included frequency of intercourse
around the time of conception as a confounding variable.
This study was retrospective and population‐based, utilizing data from the ongoing Norwegian Mother
and Child Cohort Study (MoBa). The MoBa study aims to enroll 100,000 pregnant women from 52
hospitals and birthing centers throughout Norway. Available to the NIEHS researchers were 45,132
women participants, of whom 26,303 met the study criteria and included the women's reports of the
man's height and weight. Of these women, 12 percent (3,113) were infertile. A BMI of > 25, calculated
from the man's height and weight, was considered overweight, and a BMI > 30 was defined as obese.
The researchers found that infertility was significantly related to the man's BMI, with overweight men
having a 19% increase in infertility (OR = 1.19: 95% CI = 1.03–1.37) and obese men having a 36%
increase incidence of infertility (OR = 1.36: 95% CI = 1.12–1.62). When the odds ratios were adjusted
for coital frequency, there was not much of a change in results with an OR of 1.20 for overweight men
and an OR of 1.36 for obese men. The results did not change as well when adjusted for age and parity
of the woman. The researchers speculated that the increase in infertility among obese men was due to
a decrease in reproductive hormone levels and a decrease in sperm production. They also speculated
that weight loss would improve their chances of conception.
Comments: Fertility awareness and NFP teachers working with couples who wish to achieve a
pregnancy should assess the BMI levels of both the woman and her male partner. If either has a BMI
over 25, weight loss might be recommended. It would be interesting to know if targeted intercourse
during peak fertility as determined by fertility monitoring methods would increase the pregnancy rates
or obtain the same results as found in this study?

Variability in LH Surge Found among Young Ovulatory Women
In order to better understand physiological pathology of the menstrual cycle, one must first know the
physiological norms of the menstrual cycle. Monitoring the menstrual cycle for potential health
concerns, such as heart disease, has been recommended by a number of authors and the American
Pediatric Association. There is a need to learn more about the physiological norms of the menstrual
cycle and their relationship to the health of the woman. Therefore, researchers from the New Jersey
Medical School recently conducted a study to determine the patterns of the luteinizing hormone (LH)
surge among normal ovulating young women as expressed in urinary outputs (S.J. Park, L.T. Goldsmith,
J.H. Skurnick, A. Wojtczuk, and G. Weiss, “Characteristics of the Urinary Luteinizing Hormone Surge in
Young Ovulatory Women,” Fertility and Sterility 88 [2007]: 684–690).
The participants for this study were 46 volunteer women between the ages of 20–35 with menstrual
cycles between 21–35 days in length. The participants collected a daily first void urine sample for one
menstrual cycle (i.e., from the first day of menses through the entire menstrual cycle). The urine
samples were assayed in a laboratory for LH, follicle stimulating hormone (FSH), estrone conjugate

(E1C), and pregnanediol‐3‐glucuronide (PDG). The E1C/PDG ratio was used to estimate the day of
ovulation.
The results showed that of the 46 women 43 (93.5%) had an ovulatory cycle. The mean length of the
menstrual cycles was 29 days (SD=4.0; Range 22–43 days), the mean follicular phase was 17.0 days
(SD=3.6; Range 10–29), and the mean luteal phase length was 12.1 days (SD = 1.57; range 9–16 days).
The researchers found that the LH surge varied in configuration with the onset being either rapid or
gradual and the configuration being spiked, biphasic, or plateau in shape. They also discovered that the
presence of an LH surge does not always result in an ovulation. They also found that the FSH rise or
surge did not always coincide with an ovulatory event. However, when there was an E1C rise before
the LH surge, there was always an ovulatory event.
The researchers concluded that the patterns of LH surges are variable and that the FSH rise is not
essential for ovulation. However, they also confirmed that the E1C rise was critical for the initiation of
the LH surge.
Comments: I found it interesting that the LH surge has many different patterns. This is not surprising,
since there is a lot of variability in follicular development and resultant hormonal production. Of
interest is that the LH surge or rise (as defined in this study) actually occurred on average over 7.6
days, (i.e., from the first rise from baseline readings until the LH surge returned to baseline).
Furthermore, not all LH surges resulted in ovulation. As the author stated, this has clinical implications
for women who use LH ovulation detection kits to time intercourse for achieving a pregnancy. Based
on this information, those women who use a hormonal monitor to detect the rise of estrogen before
the LH surge would have a better chance at achieving pregnancy by using menstrual cycles that
indicate both the estrogen rise and LH surge. I also wonder if some of the LH test kits miss the LH surge
in the biphasic LH cycles, where the LH peak is only around 28 mIU/mg.

Sialidase Activity of Female Cervical Mucus Highest in Ovulatory Phase
It is well known by natural family planning and fertility awareness teachers that the rheological
properties of cervical mucus change during the menstrual cycle in response to estrogen and
progesterone. Human cervical mucus is primarily composed of mucins and glycosylated proteins
secreted by the epithelial cells in the endocervical canal and vaginal mucosa. However, it has been
speculated that the changing rheological properties of cervical mucus are not due to the protein
structures of the mucins but, rather, to their carbohydrate components and, in particular, the
oligosaccharide moieties of mucins, i.e., sialic acid (a nine carbon sugar). It is also thought that sialic
acid‐modifying enzymes, such as sialidases, are important for proper development of physiological
functions of sperm, e.g., sperm capacitation and sperm progression in the female genital tract. Most
studies on the presence of sialic acid and sialidase activity do not take into account the timing of the
women's menstrual cycle. Therefore, researchers from the University of Siena, Italy, conducted a study
to describe the endogenous sialidase activity in cervical mucus during the phases of the menstrual
cycle and during pregnancy (F. Flori, F. Secciani, A. Capone, E. Paccagnini, S. Caruso, M.G. Ricci, and R.
Focarelli, “Menstrual Cycle‐Related Sialidase Activity of the Female Cervical Mucus Is Associated with
Exosome‐Like Vesicles,” Fertility and Sterility 88 [2007]: 1212–1219).

The researchers obtained 158 women volunteers between the ages of 17 and 45 and collected cervical
mucus samples (with sterile cotton swabs) during a gynecological exam. The samples were classified as
to when during the menstrual cycle the samples were collected, i.e., days 5–11 were considered the
pre‐ovulatory phase, days 12–16 the ovulatory phase, and days 17–29 the post‐ovulatory phase. They
also collected samples from 150 women during weeks 27–39 of pregnancy. The cervical mucus samples
were assayed for sialidase activity, centrifuged, and observed under an electron microscope.
The researchers found that sialidase activity reached a maximum during the ovulatory phase of the
menstrual cycle. They also found significant sialidase activity in the cervical mucus of pregnant women.
When the sialidase was observed under electron microscope, they saw membrane vesicle structures
that they speculated might facilitate intercellular communication before and after fertilization. The
researchers concluded that female cervical mucus contains endogenous sialidase that increases during
the fertile phase of the menstrual cycle—which helps to change the rheological properties of cervical
mucus which serves to facilitate sperm progression.
Comments: This study provides some good basic biological science of the nature and function of
cervical mucus during the menstrual cycle. It would be interesting to see a more precise indication for
the timing of the samples during the menstrual cycle either through LH testing or other natural
biological indicators of ovulation like BBT and/or self‐observed peak in cervical mucus.

Two New Antimicrobial Factors Found in Human Cervical Mucus
Infections in the female genital track are known to be deleterious for fertility, for the fetus, and for
maintaining a pregnancy. The vagina is a microbe‐rich environment, but the uterine environment is
sterile. Cervical mucus serves as a filtering and anti‐microbial host defense system between the vagina
and uterus. Although the anti‐microbial activity of cervical mucus has been established, few anti‐
microbial factors have been identified and purified. Therefore, Chinese scientists sought to identify
new anti‐bacterial molecules in human cervical mucus (L. Ming, P. Xiaoling, L. Yan, L. Wang, W. Qi, Y.
Xiyong, W. Boyao, and H. Ning, “Purification of Antimicrobial Factors from Human Cervical Mucus,”
Human Reproduction 22 [2007]: 1810–1815).
The participants for this study were 8 healthy volunteer women between the ages of 24–35 (mean age
26) with a parity of 1 and at least one year after the delivery of their child. A specimen of cervical
mucus was obtained by a 1 ml syringe from the cervix of each volunteer 3–4 days after menstruation.
The samples were chemically analyzed for anti‐microbial proteins.
The researchers found that the cervical mucus was a viscous hydrogel weighing between 0.15 and 0.30
g, with a median pH of 7.2, range 6.4–8.0. The researchers were able to discover two anti‐microbial
effectors (i.e., antibacterial peptides): 1) a high‐mobility group nucleosomal binding domain (HMG N2)
and 2) a secretory leukocyte peptidase inhibitor (SLPI). They concluded that these two anti‐microbials
serve as and constitute part of the cervix immune surveillance and defense system against pathogens
in the human reproductive system.
Comments: NFP and FA teachers need to be aware of and understand the female reproductive system,
especially those components that involve biological markers of fertility, such as cervical mucus. It

would be good to have further studies to examine the makeup of anti‐microbials in cervical mucus
during the different states of the menstrual cycle and, in particular, during the fertile phase.

Women Unaware of Risks and Complications in Delaying Childbearing
Women in Western developed countries are increasingly delaying childbearing to a later age due to
career development. Many of these women may be unaware of the potential maternal and fetal
complications among older women. Researchers from Aberdeen University sought to determine
women's awareness related to issues (social and medical) to delayed childbearing (A. Maheshwari, M.
Porter, A. Shetty, and S. Bhattacharya, “Women's Awareness and Perceptions of Delay in
Childbearing,” Fertility and Sterility 90 [2008]: 1036–1042). The researchers were also interested in
whether there was awareness of the limitations of artificial reproductive therapies among two groups
of women: 1) women who were unsuccessful in achieving a pregnancy and were currently seeking
infertility treatments, and 2) women who were currently pregnant.
The participants for the study were 772 women who were approached at the Aberdeen University
Maternity Hospital, 8 of which refused to participate. There were 382 in each group, i.e., the infertility
and the pregnant groups of women. They were all administered a 32‐item questionnaire that
ascertained their awareness of the limitations of infertility treatments, age limits for access to fertility
treatment, and tests for the prediction of fertility.
The researchers found a higher portion of women in the sub‐fertile group who sought pregnancy after
age 30 compared to the pregnant group. There was a higher portion of women in the sub‐fertile group
that used contraception in the past compared to the pregnant group. Most of the women in both the
sub‐fertile group (85%) and the pregnant group (77%) thought that IVF treatments could overcome the
effects of age even though they knew that fertility decreased with age. Most women in both groups
(86% and 85%) were aware that delaying childbearing increased the risk for a child with trisomy 21.
The authors concluded that most women they surveyed were aware of the risks of delaying childbirth
to a later age, but were misinformed erroneously that IVF would reverse the effects of age.
Comments: Of interest, among the sub‐fertile women in this study, over 80% felt that fertility
decreases considerably among women between the ages of 30–39; however, about 40% felt that IVF
would be able to reverse the effects of aging. Most of the women in both groups (>75%) felt that first‐
time motherhood after the age of 55 was unacceptable. One of the implications that this study has for
NFP/FA teachers is that they probably will be seeing more older women seeking pregnancy for the first
time. The NFP teachers need to be honest about the chances for achieving pregnancy with normal
intercourse and with IVF treatments.

Contraception
Flip Chart Contraceptive Counseling Fails to Decrease Contraceptive Discontinuation
Contraceptive discontinuation is considered a major reproductive problem since there is a relatively
high rate of unintended pregnancies during this period. Furthermore, there is a very high rate (> 50%)
of discontinuation of hormonal contraception within the first year of use. Studies have recommended
decreasing contraceptive discontinuation within improved contraceptive counseling that includes help

in contraceptive decision making and honesty in regards to side effects—and how to manage the side
effects. In order to standardize a mechanism for better contraceptive counseling, a contraceptive
counseling tool (flip chart) was developed through Johns Hopkins University. The flipchart counseling
tool has simplified information about contraceptive methods, contraceptive decision making,
contraceptive side effects, and contraceptive benefits and risks. Researchers recently tested the effects
of using the contraceptive flipchart on contraceptive continuation among clients who seek
contraception through Nicaraguan health department clinics (D.S. Chin‐Quee, B. Janowitz, and C.
Otterness, “Counseling Tools Alone Do Not Improve Method Continuation: Further Evidence from the
Decision‐Making Tool for Family Planning Clients and Providers in Nicaragua,” Contraception 76 [2007]:
377–382).
The researchers used a quasi‐experimental design in which they determined prospectively which
Nicaraguan clinics would provide the flip chart counseling intervention and which clinics would be
considered control clinics. In the 41 experimental clinics, the contraceptive flip‐chart counseling system
was used by all trained counselors on first‐time family‐planning clients for 3–5 months. The first‐time
family‐planning clients in the 24 control clinics received standard care. There were a total of 1,633
users at the clinical sites.
After 3–5 months of intervention, the researchers found that there was no difference in contraceptive
use rate, with the experimental group at 80% and the control group 86%. In fact the control group had
a higher injectable contraceptive use rate than the experimental group. However, those exposed to the
flip chart expressed that they had a better counseling experience. The authors concluded that there is
sufficient evidence that contraceptive counseling (with or without flip charts) does not increase
contraceptive use rates. They felt that newer strategies need to be developed.
Comments: The authors admitted that, although they had control clinics, there might have been some
crossover in use of the charts system and/or that there was some good contraceptive counseling in the
control clinics. Furthermore, the flip chart was not always used in the experimental clinics. The
researchers speculated that there are other factors that influence discontinuation of contraceptive
methods, including side effects and lack of support from the husband. It should be pointed out that no
matter how much counseling there is if women experience negative side effects, like unusual bleeding,
they are not going to continue—nor should the health professional expect them to. A similar flip‐chart
counseling system could be developed and tested on NFP methods to help with NFP decision making.

Studies Show Mixed Results on the Post‐Fertilization Effects of Levonorgestrel (Plan B)
Emergency Contraception
Two recent studies in two prominent journals (Fertility and Sterility and Human Reproduction)
investigated whether there are potential post‐fertilization effects of levonorgestrel‐only emergency
contraception (EC) (R.T. Mikolajckyk and J.B. Stanford, “Levonorgestrel Emergency Contraception: A
Joint Analysis of Effectiveness and Mechanism of Action,” Fertility and Sterility 88 (2007): 565–571;
P.G.L. Latlitkumar, S. Lalitkumar, C.X. Meng, A. Stavreus‐Evers, F. Hambiliki, U. Bentin Ley, and K.
Gemzell‐Danielsson, “Mifepristone, but Not Levonorgestrel, Inhibits Human Blastocyst Attachment to
an in Vitro Endometrial Three‐Dimensional Cell Culture Model,” Human Reproduction 22 [2007]: 3031–
3037). This topic is of importance to health professionals, potential users, and health‐care facilities in
which religious or ethical codes prohibit the use or prescription of drugs that produce an early

pregnancy loss. Some states in the United States have mandated the use of EC for rape victims in all
hospital emergency rooms. So the answer to the question of whether or not levonorgestrel EC causes
an early abortion is of importance.
The first study utilized a theoretical approach to determining whether there might be a post‐
fertilization mechanism of levonogestrel‐only EC (Mikolajckyk et al., “Levonorgestrel Emergency
Contraception”). The authors did this by estimating the efficacy rates of using EC to avoid pregnancy
for up to 72 hours post‐intercourse based on known day‐specific probabilities of pregnancy and a
follicular growth model. They determined that with a disruption of ovulation alone, the potential
efficacy of EC was from 49% (with no delay in taking the drug) to 8% (taking the drug with a 72‐hour
delay). However, based on their models, with complete disruption of ovulation as the only mechanism,
the potential effectiveness of avoiding pregnancy was from 90% (with immediate use) to a low of 16%
(with a 72‐hour delay). They concluded that the gap in efficacy rates between what is reported in the
literature and what they modeled might either be explained by an overestimation of efficacy or by
some type of post‐fertilization effect.
The second study involved the use of an in vitro model with a culture model of the early luteal phase of
the human endometrium (Latlitkumar et al., “Mifepristone, but Not Levonorgestrel”). The researchers
used 46 embryos donated from an IVF clinic, of which 14 were cultured with levonorgestrel, 15 with
another anti‐progesterone drug mifepristone, and the remaining 17 embryos served as controls. They
found that none of the embryos that were cultured with mifepristone (a known abortion drug)
demonstrated endometrial attachment, while 6 of the 14 levonorgestrel embryos attached as well as
10 of the 17 control embryos. There was no difference in the rate of attachment between the control
and levonorgestrel‐cultured embryos. The authors concluded that mifepristone inhibits
embryo/blastocyst attachment but that levonorgestrel does not impair the attachment of human
embryos as determined by the in vitro endometrial environment.
Comments: While there is no statistically significant difference in these implantation rates, it might be
worth noting that the implantation rate of the controls (59%) is higher than that in the levonorgestrel
group (43%). With additional testing this could become significant, but would require quite a large
number of embryos to be killed in this experiment (∼200 in each group) in order to have enough
statistical power to detect differences—the killing of any embryos is morally unacceptable.
Of the two studies, the in vitro endometrial attachment construct study has more direct evidence and
coincides with the results from other recent studies that showed no post‐fertilization effect with the
administration of levonorgestrel. However, as the “potential for a changes in the endometrium (which
reduce the likelihood of implantation)” is noted in the prescribing information for levonorgestrel (e.g.,
see “Seasonique,” http://www.seasonique.com/docs/prescribing‐information.pdf), women should be
presented with the knowledge that Plan B has a potential post‐fertilization effect. In addition,
levonorgestrel is associated with “increased risk of several serious conditions including venous and
arterial thrombotic and thromboembolic events (such as myocardial infarction, thromboembolism, and
stroke), hepatic neoplasia, gallbladder disease, and hypertension” (ibid., 9). Therefore, if levonogestrel
is to be used, and if indeed it does not have a post‐fertilization effect, it would seem prudent to first
screen women to see if ovulation has occurred prior to administration of Plan B, and only administer
Plan B to those who have not as yet ovulated, as is commonly the case in rape protocols for some
Catholic hospitals. This would serve to minimize the risk of side effects to the women while still

permitting use when conception has not yet occurred. Both sets of researchers from these studies
recommended further research into the matter.

Post‐Fertilization Effects Influence Women's Choice of Family Planning Methods
Providing information about the mechanisms of action of family planning methods by health providers
is important for the decision‐making process of potential users. One of the concerns is whether family‐
planning methods act post‐fertilization and cause early embryo loss. Spanish researchers recently
surveyed 755 potentially fertile women in order to determine their attitudes towards post‐fertilization
effects of family‐planning methods (J. De Irala, C. Lopez del Burgo, C. Lopez de Fez, J. Arredondo, R.T.
Mikolajczyk, and J. Stanford, “Women's Attitudes towards Mechanisms of Action of Family Planning
Methods: Survey in Primary Health Centres in Pamplona, Spain,” BMC Women's Health 7 [2007]: 1–10).
The 775 female participants were between the ages of 18–49 and were approached by health
providers at 10 primary health centers in Pamplona, Spain. They were asked to complete a 30‐item
questionnaire about family‐planning methods, mechanisms of action, and medical and surgical
abortion. Of the 755, the researchers were able to obtain 581 (80%) usable questionnaires.
The researchers found that almost half of the respondents (46.3%) believed that life begins at
fertilization, and most (58.7%) felt it was important to distinguish between natural embryo loss and
those caused by family‐planning methods. A majority of respondents (57%) would not use a family‐
planning method that sometimes works after implantation of the embryo, and a large minority (39.4%)
would not use a family‐planning method that sometimes works after fertilization but before
implantation. The researchers realized that the respondents (who were mostly well educated Catholic
women) did not represent the entire population of Spanish women and recommended further studies
with other populations. The authors concluded that the results emphasize that full information about
the mechanisms of action for family‐planning methods is important for many women.
Comments: Since some bioethicists claim that NFP methods are a cause of early embryo loss due to
aging gametes, it would be interesting to know if those Spanish women would consider NFP a natural
cause. The researchers also asked an open‐ended question as to what are the most important
characteristics in choosing a method of family planning. The three highest rated responses were: 1)
efficacy (76%), 2) convenience and ease of use (53.4%), and 3) absence of side effects (28.6%).
Although most of the respondents listed their religion as Catholic, there was a low level of religiosity
among the participants based on church attendance and self‐reported importance of religion.

Oral Hormonal Contraceptive Use Increases Estrogen Receptors in Vulvar Vestibular
Mucosa
Swedish researchers sought to determine the effects of combined oral contraceptive (COC) use on the
sex steroidal receptors in vulvar vestibular mucosa in healthy women (U. Johannesson, L. Sahlin, B.
Masironi, E. Rylander, and N. Bohm‐Starke, “Steriod Receptor Expression in the Vulvar Vestibular
Mucosa–Effects of Oral Contraceptives and Menstrual Cycle,” Contraception 76 [2007]: 319–325). The
background reason for conducting this study was that this area of research has few studies, and these
same researchers recently found morphological changes in vulvar vestibular mucosa during COC use.

Furthermore, the Swedish researchers believe that there is some connection between COC use and
vestibular pain during intercourse.
The researchers recruited 45 healthy sexually active subjects of which 20 (mean age 23.7) were on
COCs for a minimum of one year (actual use ranged from 2–15 years) and 25 control women (mean age
25.6 years) who used non‐hormonal means of contraception. A vestibular punch biopsy was obtained
on the 7–11th day after the beginning of the menstrual cycle in all subjects. Serum samples for
estradiol and progesterone levels were drawn to determine the phases of the menstrual cycle. Tissue
from the punch biopsies were subjected to immunohistochemistry analysis for sex steroid receptors.
Five of the control women were determined not to have ovulated during the test cycle and were not
included in the analysis.
The researchers found that there were significantly more beta‐type estrogen receptors in the vulvar
vestibular tissue of the COC users compared to the controls (p < 0.024). They also found a greater
abundance of progesterone receptors in the vulvar tissue during the follicular phase than in the luteal
phase (p < 0.01) among the non‐COC users. They did not find any significant differences in the
abundance of progesterone, androgen, or glucocorticoid receptors between the two groups. However,
the researchers did point out a limitation in the small number of participants in each group. They
concluded that the results indicated a hormonal influence on the steroid receptor expression by ethinyl
estradiol as well as by progestins. They believed that the hormones in the COCs not only effect the
expression of the estrogen receptors but the morphology of the vestibular mucosa as well.
Comments: The Swedish researchers indicated that the clinical implication for the findings was
unknown. However, they have proposed that COCs make the vestibular tissue more sensitive and that
this is a possible reason why COC users report more sexual pain compared to non‐users. It would be
interesting to know if the increase in estrogen receptors also occurs in the cervical endometrial tissue
and is one reason why there is an increase of cervical mucus found in post‐COC users who switch to a
mucus‐based method of fertility awareness.

Return of Menses Occurs Rapidly after Use of Continuous Oral Contraception
Traditional oral hormonal contraception produces an artificial menses every 28 days due to the
withdrawal of exogenous hormones with the use of hormone‐free placebo pills or by a Pill‐free
interval. Recently, continuous oral hormonal contraception has been introduced that reduces the
frequency of artificially induced menses. There is some concern that use of continuous hormonal
contraception might delay the return of menses and ovulation. Therefore, researchers conducted a
study to determine the effect that prolonged use of continuous hormonal contraception has on the
return to fertility—with spontaneous menses as the marker of fertility return (R. Davis, R. Kroll, B.
Soltes, N. Zhang, G.S. Grubb, and G.D. Constantine, “Occurrence of Menses or Pregnancy after
Cessation of a Continuous Oral Contraceptive,” Fertility and Sterility 89 [2008]: 1059–1063).
The participants for this study were 198 women who were a subset of the 2,134 subjects (with regular
menstrual cycles of 21–35 days) who participated in a phase‐3 efficacy and safety trial of daily
continuous oral levonogestrel (LNG) 90 μg/ethinyl E2 (EE) 20 μg (trade name Lybrel) and who
completed at least 6 months of use. Most (81.8%) of the 198 subjects had completed 12 months of
Lybreal with a mean duration before enrollment of 349 days. Of the 198 participants, 187 completed

the study. Of these, 185 (98.9%) returned to spontaneous menses or became pregnant within 90 days
of stopping LNG/EE. Of the two subjects that did not experience a return of menses within 90 days,
one did so at 124 days and the other approximately 2 months after the completion of the study. The
median time to return of menses was 32 days. Furthermore, the researchers found that the length of
amenorrhea (i.e., length of use of LNG/EE) was unrelated to the time to return of menses. The authors
concluded that the inhibition of menses with continuous use of LNG/EE was readily and quickly
reversible.
Comments: NFP/FA teachers who have women coming off of continuous LNG/EE (Lybrel) to achieve a
pregnancy or to use natural methods for avoiding pregnancy can assure them that menses (and
presumably ovulation) will most likely return within 1–3 months. However, these results apply only to
those women who previously had regular‐length menstrual cycles.

Menstrual Cycle
Slow Follicular Growth Rate Contributes to Longer Follicular Phases in Adolescents
Although it is accepted knowledge that irregular menstrual‐cycle lengths are commonly experienced by
adolescent females, little is known about the mechanisms that cause the irregularities. Of particular
interest is the rate of follicular growth, follicular dynamics, and the length of the follicular phase in this
population. Researchers from the Federal University of Mato Grosso, Brazil, recently conducted a study
to verify the prevalence of long follicular phases among healthy adolescents and to correlate the phase
lengths with endocrine patterns and follicular growth rates (Z.A.F. Cabral and S.F. de Medeiros,
“Follicular Growth Pattern in Normal‐Cycling Brazilian Adolescents,” Fertility and Sterility 88 [2007]:
1625–1631).
The participants for this study were 55 healthy and sexually active female adolescents between the
ages of 14 and 19 (mean age 16.9) who attended an adolescent clinic for the purpose of obtaining birth
control. The participants received daily ovarian ultrasound measurements (of follicular growth) from
days 2 to 5 of their menstrual cycle until ovulation was confirmed through visual collapse of the
dominant follicle. In addition, blood was drawn from days 2 to 5 of the menstrual cycle to determine
FSH, LH, and estradiol (E2) levels.
The researchers found that the menstrual cycle ranged from 25 to 35 days (with a mean of 29.5 days,
SD = 1.6). The follicular‐phase length was a mean of 16 days, SD = 0.5 days. Twenty‐five of the
participants had follicular phase lengths greater than 16 days. There was a mild inverse correlation (r =
–0.464) between FSH levels and follicular‐phase length, but there was no significant correlation
between follicular‐phase length and LH and basal E2 levels. The researchers did find a faster speed of
follicular growth among the adolescents with follicular phases 16 days or less compared to those with
follicular phases greater than 16 days, i.e., 1.33 mm/day vs. 0.88 mm/day. The researchers concluded
that long follicular‐phase lengths were common among adolescents and are probably a result of slow
follicular growth.
Comments: Natural family planning (NFP) and fertility awareness (FA) teachers involved with
adolescents can expect menstrual‐cycle length variability among their adolescent clients. According to
this study the variability is most likely a result of the variation in rate of follicular growth. It should be
pointed out, however, that this was a rather small study with only 55 participants. A recent study by

this author also found a mean of 16 days for follicular length among 141 healthy women with a mean
age of 29 (R. Fehring, M. Schneider, and K. Raviele, “Variability in the Phases of the Menstrual Cycle,”
Journal of Obstetric, Gynecologic, and Neonatal Nursing 35 [2006]: 376– 384). So this small cohort of
adolescents did not display variability much different than a larger population of healthy women.

Time to Pregnancy Shortened by Focused Intercourse (Theoretically)
Couples in the United States and other Western nations are delaying marriage and postponing starting
a family (i.e., having children) for the purpose of developing careers and stabilizing relationships.
Delaying childbirth to an older age brings with it the risk of a diminished fertility and the expense of
infertility diagnosis and treatment. There is some evidence that focused intercourse during the six‐day
fertile phase of the menstrual cycle will aid in a quicker time to pregnancy and avoidance of infertility
care. However, what is not known are the optimal patterns of frequency and timing of intercourse to
achieve pregnancy. Research statisticians from Italy and the United States sought to determine—based
on an existing data set of menstrual cycles and utilizing Baysian analysis—the optimal timing and
frequency of intercourse to achieve a pregnancy (B. Scarpa, D.B. Dunson, and E. Giacchi, “Baysian
Selection of Optimal Rules for Timing Intercourse to Conceive by Using Calendar and Mucus,” Fertility
and Sterility 88 [2007]: 915–924).
The data set included information from 193 women who were taught a mucus only (Billings) method of
natural family planning. These women produced 2,755 menstrual cycles of data and 177 pregnancies.
However, of these 193 women, 191 produced 2,536 complete data cycles, and, of these 191 women,
132 of them achieved 161 clinical pregnancies. The median length of the cycles in the data set was 28
days with a range of 18 to 76 days. The menstrual‐cycle data included acts of intercourse and cervical
mucus secretions descriptions. The investigators rated the cervical mucus descriptions on a scale from
1 to 4, with 1 = no mucus, dry sensation to 4 = slippery, wet, stretchy, clear mucus. The mean age of
the 2,536 women participants was 29.95 years and their male partners 32.64. Each woman produced a
mean of 13.28 cycles of data.
The researchers developed multiple scenarios of intercourse patterns with or without mucus during
the middle, most fertile days of the menstrual cycle (i.e., days 6–25) and during the estimated highest
probability of fertility (i.e., days 13–17). They discovered that when intercourse is focused only on
those days and not outside of days 6–25, the highest probability of pregnancy was with intercourse on
each day from days 6–25 (i.e., 20 acts of intercourse). This pattern of daily intercourse yielded a cycle
probability of conception = 0.687. This pattern also resulted in only 3 cycles of trying to achieve a 90%
pregnancy rate. For couples who focused intercourse on the high‐rated fertile mucus (i.e., a number 4
rating) days (13–17) of the menstrual cycle, the cycle probability of conception decreases to 0.347,
with a mean intercourse rate of 2.42 days. With this scenario, the number of cycles to achieve a 90%
pregnancy rate would take an average of 15 cycles.
Interestingly, if the couples have intercourse (on average) every other day (regardless of the mucus
rating) and focus on days 10–18 of the menstrual cycle, the cycle probability of conception drops only
slightly to 0.647 and increases one additional cycle to pregnancy (i.e., 4 cycles) to achieve a 90%
pregnancy rate.

The researchers also analyzed intercourse scenarios not only with intercourse during the middle of the
cycle (i.e., days 6–25) but also with 1/7th of the acts of intercourse outside of that range. According to
the data set, this increases the probability of pregnancy. For example, if the couples have intercourse
every other day (i.e., a mean of 9 days of intercourse between days 10–18), and have 1/7th of the acts
of intercourse outside of that range, the cycle probability of pregnancy is 0.654 and a 90% pregnancy
rate within 3 cycles of trying.
The authors concluded that focusing intercourse on days of high fertile mucus (i.e., 4‐rated mucus)
would be useful for couples to shorten their time to pregnancy and not require a high frequency of
intercourse. They also admitted that just using a calendar method and having intercourse on average
every other day (during the estimated fertile window) and occasionally outside of the fertile window
are sufficient. With this scenario, mucus identification does not add to the efficiency of achieving
pregnancy.
Comments: The intercourse scenarios presented in this study are theoretical and need to be tested in
actual life and, in particular, with randomized control trials—for example comparing calendar‐based
intercourse patterns versus high‐fertile‐mucus‐focused intercourse patterns. It seems, based on this
theoretical data, that intercourse every other day during the estimated fertile phase of the cycle has
very high probability of efficiently achieving a pregnancy. This article was very similar to a recent article
by the same authors that focused on the statistical models used for this study (B. Scarpa and D.B.
Dunson, “Bayesian Methods for Searching for Optimal Rules for Timing Intercourse to Achieve
Pregnancy,” Statistics in Medicine 26 [2007]: 1920–1936).
It would be interesting to know if an externally observed mucus database is the best to determine
efficient intercourse patterns to achieve pregnancy. One of the reasons for skepticism of this type of
data set is that cervical mucus is not very efficient or accurate in estimating the fertile window. Based
on the data presented in this article, the mean number of days of 2‐ to 4‐rated mucus was 18.92 days
for women between the ages of 20–26 and ranged from 15–19 days for all women in the data set.
Since the mean length of the cycles was 28 days, this means that on average more than half the days
had mucus‐rated days, and, on average, cervical mucus overestimates the fertile window by a factor of
3.

Anti‐Mullerian Hormone Found to Be Best Predictor of Menopausal Transition
The years leading up to menopause can be a difficult time for women using natural methods of family
planning due to the variability of the menstrual cycles, increased anovulatory cycles, and increased
menopausal symptoms. Also difficult at this time, are the decisions to be made in regards to use of
supplementary hormones. In 2001, experts on the physiological changes of the menstrual cycle
developed what is called the “Stages of Reproductive Aging Workshop” and the STRAW model of
menopausal transition. The STRAW has 5 stages leading up to the final menstrual period, i.e., phases –
5 to –3 are the early, peak, and late reproductive phases, and stages –2 to –1 are the early and late
menopausal transition phases. These stages are primarily based on the increased variability in the
menstrual cycles and increased levels of FSH. Researchers from the University of Sidney, Australia,
were interested in determining and clarifying the endocrine changes during the stages of menopause
transition as identified by the STRAW model (G.E. Hale, X. Zhao, C.L. Hughes, H.G. Burger, D.M.
Robertson, and I.S. Fraser, “Endocrine Features of Menstrual Cycles in Middle and Late Reproductive

Age and the Menopausal Transition Classified according to the Staging of Reproductive Aging
Workshop [STRAW] Staging System,” Journal of Clinical Endocrine Metabolism 92 [2007]: 3060–3067).
To do so, the researchers measured key hormones during the menstrual cycles of 77 women recruited
through community advertisement. The women volunteers included 21 between the ages of 21 to 35
and 56 between the ages of 45 to 55. The older cohort of women were categorized based on the last 3
stages of the STRAW Model, i.e., stage –3, the late reproductive age but regular menstrual cycle
lengths (LRA); stage –2, early menopausal transition with variability in menstrual cycle lengths greater
than 7 days (EMT); and stage –1, the late menopause transition with at least one menstrual cycle
interval lasting 60 days or more (LMT). The women collected menstrual cycle diaries that included first
morning basal body temperatures for 3–6 months. Researchers collected blood samples three times a
week through the first 7 days of the next menstrual cycle. The blood samples were analyzed for FSH,
LH, estradiol (E2), progesterone (P), inhibin A (INHS), inhibin B (INHB), and anit‐Mullerian Hormone
(AMH).
Of the 93 subjects, 77 women contributed data for the study, and 21 were classified as mid‐
reproductive age (MRA), 16 in the LRA stage, 17 in EMT, and 23 in LMT. They found that ovulatory
cycle lengths were shorter in the LRA group compared to the MRA and EMT group, but luteal phases
were similar in all four groups. They discovered that FSH, LH, and E2 levels increased with the
progression of the STRAW stages, and mean P levels decreased. Inhibin levels also decreased steadily
across the STRAW stages but were undetectable in the anovulatory and long ovulatory cycles. The
AMH decreased steadily and markedly across the stages of menopause transition. The researchers felt
that the marked changes in AMH might be a good marker of indicating and predicting menstrual‐cycle
stage changes. However, they indicated that large cohorts of women would be needed to verify these
findings.
Comments: From a natural methods perspective, researchers should have to provide evidence that the
changes in AMH are more precise in predicting menopause transitions than normal menstrual‐cycle
variability and natural biological markers of fertility. For example, are the AMH changes better
predictors than the criterion of having menstrual‐cycle length variability greater than 7 days and having
menstrual‐cycle lengths greater than or equal to 60 days? These changes could be found among
women who use natural methods of fertility regulation or those women who just monitor the lengths
of their menstrual cycles. Natural methods of fertility monitoring would be a less expensive means of
monitoring menopausal transitions compared to having blood work to measure AMH levels.

In Depth Stress and Menstrual Cycle Variability
Stress is a common experience in modern Western cultures. For women using fertility awareness
based (FAB) methods of family planning, the effect of stress on the menstrual cycle is of concern. In
particular the concern is whether stress causes menstrual‐cycle variability, suppression or delay in
ovulation, and disruption in the biological signs of fertility. When women are under stress, the
impression is that FAB methods are more difficult to use because of menstrual cycle variability and
confusing biological indicators of fertility.
Social and medical scientists have accumulated many studies to show that as stress events accumulate
during a calendar year (or longer), the more likely the person will experience a stress‐related illness.1

Researchers have developed a list of events from death of a spouse at the top to a minor parking ticket
at the bottom, with marriage is ranked as the number two stressor just below death of a spouse. The
more life changes and the higher on the list are the life changes that an individual experiences, the
more likely she will experience stress‐related health problems. Anecdotally, NFP teachers often
comment that the menstrual cycle during the week of the marriage event is extremely variable as a
result of the stress of the marriage and marriage preparations.
The research evidence on the effects of stress on the menstrual cycle is mixed.2 A study conducted
with women from India showed that women who worked in physical‐type jobs, such as farm or craft
work, had significantly longer cycles than women who worked in sedentary jobs, such as clerical work.3
Another study among U.S. and Italian nurses found that there was a significant relationship between
the perceived stress of their jobs and longer and monophasic cycles.4 However, the Italian nurses who
worked with rotating shifts compared to fixed shifts had significantly shorter menstrual cycles and
shorter luteal phases determined by the basal body shift as the proxy indicator for ovulation.
Two recent studies indicated that the experience of stress was related to shorter menstrual cycles.5
One study was conducted with 276 healthy, premenstrual U.S. women.6 The researchers found that
those women in “stressful jobs” had more than twice the risk of having shorter menstrual cycles than
those women in non‐stressful jobs. However, there was no relationship between the participants’
perceived stress and menstrual‐cycle variability. Another study showed that there was no relationship
between menstrual‐cycle length and accumulation of stressful life events over a calendar year among
206 healthy U.S. women.7 However, women with increased stress levels over a 2‐year period had
significantly shorter menstrual cycles compared to women with less stress.
Two other studies found no relationship between measures of stress and variability of the parameters
of the menstrual cycle.8 One study measured urinary stress hormones (adrenaline, noradrenaline, and
cortisol levels) and a psychological measure of mood states among 34 healthy menstruating women.9
Neither the psychological measure of stress nor the urinary stress hormones correlated with
menstrual‐cycle variability. Of interest was that the psychological measure of stress through perceived
moods states did not correlate with the urinary measures of the stress hormones. Finally, a recent two‐
part study of both ovarian hormones and stress hormones found no differences in stress hormone
levels or ovarian hormonal levels between 95 female students taking the medical school entrance
exam (the stressor) and 27 female controls.10 The researchers also found no differences in pre‐ and
post‐entrance exam test stress hormone levels within the medical school entrance exam group.
Therefore, the evidence of stress effects on the menstrual cycle is not conclusive. Part of the reason for
the mixed results is the mixed means of measuring stress (mentally and physically) and measuring
menstrual‐cycle changes. Furthermore, there is no consistent meaning of “stress” whether the stress is
chronic or acute, and how much stress is being experienced—and whether the stress was physical or
psychological. In order to have a better idea of how stress affects the menstrual cycle, there needs to
be a more standardized means of measuring stress and menstrual‐cycle parameters.
Researchers at Marquette University recently analyzed the effects of stress on the menstrual cycle by
analyzing the effect marriage has on the menstrual cycle. As mentioned previously, marriage is
considered a very high level life‐experience stressor. They measured the length of the menstrual cycle
and the length of the luteal and follicular phases among 13 women during the pre‐wedding menstrual

cycle, the wedding menstrual cycle, and the next two post‐wedding menstrual cycles. The 13 women
were between the ages of 20 and 37 (mean age 26.5, SD=5.28), and all 13 had regular cycle lengths.
Repeated measure analysis indicated that there was a significant change in the length of the menstrual
cycle from the pre‐to the two menstrual cycles post the wedding cycle. Post hoc statistical testing
indicated that the pre‐wedding menstrual cycle length and the last menstrual cycle length (from the
wedding cycle) were significantly shorter than the menstrual cycle experienced during the wedding
month. See table 1 below.

Although there was no significant change in the length of the follicular phase (as indicated by the day
of the peak day of cervical mucus) and the length of the luteal phase, table 1 results do show that the
peak day was almost (on average) two days earlier during the wedding cycle than the pre‐wedding and
last cycles. The power to detect changes was low since there were only 13 participants in this analysis.
Therefore, the data suggest that stress has the effect of shortening the menstrual cycle mostly due to a
short follicular phase. This would indicate that rather than suppressing ovulation, stress actually
stimulates ovulation to occur earlier. The stress hormones might be stimulating the reproductive
hormones. These results coincide with the two studies mentioned above that provided evidence that
stress shortens the menstrual cycle.

Fertility awareness methods and NFP method textbooks generally report that stress will lengthen the
menstrual cycle and/or delay or suppress ovulation.11 According to T. Weschler, stress will lengthen the
menstrual cycle and either delay or suppress ovulation.12 Weschler and others also indicated that the
cervical mucus sign will be diminished or that there will be a buildup, tapering off, and then another
buildup of cervical mucus during a stress cycle.13 Some methods call this a double peak.14 The double
peak in the mucus buildup supposedly indicates a suppression and delay in ovulation. E. Clubb and J.
Knight also wrote that if stress is severe enough, ovulation will be completely suppressed.15 Several of
the texts mentioned that, besides the double‐peak phenomenon, the basal body temperature shift will
be delayed for up to one week.16 Several of the texts provided example charts with delayed ovulation,
double buildup of mucus, and longer menstrual‐cycle lengths. One even mentioned the wedding cycle

and provided an example of the menstrual cycle recorded during the wedding month.17 None of the
textbooks provided evidence of the effects of stress other than anecdotal cases.
A number of reproductive physiological texts concur with the NFP/FA textbooks that stress will cause a
hypothalamic response possibly leading to anovulation and amenorrhea.18 This happens with high‐
intensity runners or women who participate in a high‐intensity‐type sport activity. However, the
amenorrhea (and anovulation) is usually not due to the running or high intensity of the sport but to
having insufficient nutritional energy to make up for the deficit.19
In summary, the effects of chronic and acute stress on the menstrual cycle are mixed. Generally, they
will include a decrease in the length of the cycle and the follicular phase. However, if the stress is acute
enough, ovulation will be suppressed. One of the big indicators of how the menstrual cycle will react is
the energy factor—does the body have enough energy to sustain ovulation. Most women's bodies do,
especially if they maintain an adequate diet, moderate exercise, and appropriate amounts of sleep and
rest. However, if you have young women who are avid runners or who are trying to starve themselves
into a smaller‐sized wedding dress, ovulation might be delayed and suppressed. As always, a balanced
lifestyle of moderate exercise, appropriate diet that meets the energy requirements of the body, rest
and sleep, and good mental outlook will help to moderate stress and the effects it will have on the
menstrual cycle. Monitoring the normal parameters of the menstrual cycle through NFP can also be a
way of monitoring a healthy lifestyle.

Current Medical Research Summer/Fall 2008
Richard J. Fehring, Ph.D., R.N.
Self‐Assessment of Cervical Pupil Sign as a Possible New Natural Family Planning Method
It is well known among natural family planning (NFP) and fertility‐awareness method (FAM) teachers
that the cervical opening (i.e., cervical os) softens and opens during the peak of fertility, and then
closes and tightens soon after ovulation. Users of the symptothermal method of NFP are taught to feel
for this opening of the cervical os by the insertion of clean fingers into the vagina and to estimate
“blindly” the cervical opening. Researchers from Belgium recently conducted a study to determine if
women could accurately measure the fertile phase of the menstrual cycle by the self‐use of a lighted
vaginal speculum called the Femiscope (I. Brosens, P. Hernalsteen, A. Devos, B. Cloke, and J.J. Brosens,
“Self‐Assessment of the Cervical Pupil Sign as a New Fertility‐Awareness Method,” Fertility and Sterility
91 [2009]: 937–939).
Twenty volunteer women between the ages of 21–44 with regular‐length menstrual cycles participated
in the study. Of these 20 women, 7 were nulliparous, and 13 had one or more vaginal births. All of the
women had previous experience with NFP methods. These women were taught how to self‐assess
their cervical os by use of the Femiscope on a daily basis from day 8–18 of their menstrual cycles. They
were instructed to rate the cervical opening from 1–3, with 1 = less than 1 mm, 2 = 1 to 3 mm, and 3 =
greater than 3 mm. The 3 rating was considered the “pupil” sign. The women volunteers also self‐
assessed their cervical mucus on a 1–6 rating scale and measured their daily basal body temperature
(BBT). The BBT shift in temperature was used to verify the estimated day of ovulation. These women

produced 58 menstrual cycles of data over a 6‐month time period (2–3 cycles per woman). All 58 of the
menstrual cycles showed a BBT shift and a 9–14 day luteal phase.
However, in only 38 (63%) of the menstrual cycles did the self‐observation of the cervical opening
define the fertile phase, and in only 36 (62%) of the menstrual cycles did the self‐observed cervical
mucus sign correlate with the fertile phase. The length of the fertile phase by the pupil sign was
between 1–11 days (mean 3.1) and by the cervical mucus observations 2–8 days (mean 4.8 days). The
researchers determined that the fertile phase by the pupil sign was significantly shorter and more
consistent than when estimated by the cervical mucus sign. The authors concluded that the self‐
assessment of the cervical pupil sign was feasible when used to estimate the fertile phase of the
menstrual cycle. They also concluded that the self‐assessment of the cervical os and the pupil sign
needs further investigation.
Comment: Insertion of a plastic speculum to view the cervical opening is invasive. Ten of the 20
volunteer women in the study reported some pain and discomfort with this method. The researchers
will need to show how the use of the Femiscope and the self‐assessed pupil sign is an advantage over
the other traditional, natural, biological indicators, such as using BBT and measuring urinary
reproductive hormones. Furthermore, future studies should include more objective measures of
ovulation, such as LH levels or serial ultrasound of the developing follicle, to correlate with the pupil
sign.

Menstrual Cycle Length Found to Correlate with Reduced Ovarian Reserve and Pregnancy
Outcome
It is well known that fertility decreases with age, and that this decrease is largely due to reduced
ovarian reserve, i.e., a decreased follicle/oocyte pool in the ovary. It is also known that mean
menstrual‐cycle length gradually decreases from a maximum length for women in their 20s to a low
when in their late 40s. The last 2 years before menopause is a time when the menstrual‐cycle length
and menstrual‐cycle length variability increases dramatically. Based on this information, researchers
from Sweden wished to determine if menstrual‐cycle length could be used to predict ovarian reserve
(T.B. Brodin, R. Bergh, L. Berglund, N. Hadziosmanovic, and J. Holte, “Menstrual Cycle Length Is an Age‐
Independent Marker of Female Fertility: Results from 6,271 Treatment Cycles of in Vitro Fertilization,”
Fertility and Sterility 90 [2008]: 1656–1661).
The participants for the study were women seeking IVF treatments for infertility. The researchers
recorded the self‐recalled menstrual‐cycle length. Some of the women participants had menstrual‐
cycle diaries, others did not. The outcomes were pregnancy, delivery rates following IVF treatment,
and follicular stimulating hormone (FSH) levels. The data was taken from 6,721 IVF treatment cycles.
As with past studies, the researchers found that increasing age was associated with decreasing mean
menstrual‐cycle length. However, they also found that pregnancy and delivery rates also correlated
positively with increasing menstrual‐cycle length. For example, they found that the pregnancy rate was
almost double for women with mean menstrual‐cycle lengths greater than 34 days compared with
women with mean menstrual‐cycle lengths shorter than 26 days. The researchers also found that
menstrual‐cycle length was associated with FSH stimulation and embryo quality. They concluded that

menstrual‐cycle length was associated with positive IVF outcomes regardless of age, and that
menstrual‐cycle length could possibly be used as a simple marker of ovarian reserve.
Comments: Although the results seem clear, there are several concerns with the study. The first is the
use of recall data for menstrual‐cycle length. Although there is some correlation with recall, some
studies have shown that there is a considerable amount of error in recall of menstrual‐cycle length.
The second problem is that the researchers used only women with infertility problems. A stronger
study would have involved women with regular fertility seeking pregnancy who tracked their cycle
length prospectively, i.e., women using NFP or fertility‐awareness methods. In addition, the immorality
of IVF makes the conduct of this study unacceptable. However, these results do provide another
reason for women to monitor menstrual cycles, i.e., to be aware of ovarian reserve to better assess
their ability to become pregnant using natural methods.

12‐Month Typical‐Use Failure Rate of Fertility‐Awareness‐Based Methods Estimated to
Be 25 Percent
Researchers from the Alan Guttmacher Institute and Princeton University recently analyzed the data
from the 2002 (Cycle 6) National Survey of Family Growth (NSFG) to determine contraceptive failure
rates of the most commonly used methods of family planning in the United States (K. Kost, S. Singh, B.
Vaughan, J. Trussell, and A. Bankole, “Estimates of Ccontraceptive Failure from the 2002 National
Survey of Family Growth,” Contraception 77 [2002]: 10–21). They also compared the 2002 data with
the 1995 NSFG data to determine trends in contraceptive failure among these methods. A rationale for
analyzing this data was that contraceptive failure is the biggest cause of unintended pregnancy and, as
a result, higher abortion rates. Another reason is that the U.S. Department of Health and Human
Services has stated a goal of reducing the unintended pregnancy rate as a result of contraceptive
failure from the estimated 13% in 1995 to 7% in the year 2010.
The NSFGs are periodic population‐based surveys conducted by the National Center for Health
Statistics on women between the ages of 15–44. The 2002 NSFG composed a sample of 7,643 women.
The methods of family planning that the researchers analyzed were the five most commonly used
methods in the U.S. These methods are injectable contraceptives, oral contraceptives (i.e., the Pill), the
male condom, withdrawal, and fertility‐awareness‐based (FAB) methods (that included calendar,
mucus, temperature, periodic abstinence, and natural family planning). The researchers used life‐table
analysis to determine typical‐use failure rates at 3, 6, and 12 months of use. They also used a statistical
technique to correct for under‐reporting of abortion. Typical use unintended pregnancy rates includes
imperfect or inconsistent use of the methods.
The 12‐month probability of failure for the five contraceptive methods (when corrected for the
underreporting of abortions) were as follows: 6.7% for injectables, 8.7% for the pill, 17.4% for male
condom, 18.4% for withdrawal, and 25.3% for FAB methods. The overall total unintended pregnancy
rate for all methods combined was 12.4%. In contrast the 1995 NSFG unintended pregnancy rates were
as follows: 5.4 % for injectable, 8.8% for the pill, 17.8% for male condom, 28.4 % for withdrawal, and
22.6% for FAB methods. The overall unintended pregnancy rate was 14.9%. Although not statistically
significant, the unintended pregnancy rate for FAB methods was 2.7% higher in 2002 than in 1995.

Other findings of interest were: 1) women aged 30 and older were less likely to experience unintended
pregnancies; 2) non‐Hispanic black women were the most likely sub‐group race to experience
unintended pregnancies: 3) the unintended pregnancy rate among poor women below the poverty
level remained high in 2002, i.e., at a 19.9% level; and 4) co‐habitating women have the highest risk of
having unintended pregnancies, 9.5% in 2002.
The authors concluded that there was no clear improvement in contraceptive failure rates from 1995–
2002, and that failure rates were particularly high for condom, withdrawal, and FAB methods.
Comments: The failure rates for FAB methods are somewhat skewed in that they include not only the
more modern methods of mucus and temperature monitoring, but also “self‐devised” calendar or
counting methods. These self‐devised methods would most likely be used by the highest risk groups
(e.g., poor, single, sexually active adolescent women), and, thus, these methods would have increased
failure rates. It would be good to see a comparison of the 1995 to 2002 data with the “true” natural
family planning methods that include self‐observations of markers of fertility among married women.
However, the number of users in this category would probably be too low for analysis purposes.

Normative Statistical Parameters of the Menstrual Cycle
Knowing the normal parameters of the menstrual cycle is important for health professionals, so that
they can recognize abnormal patterns that might signal significant health problems, such as polycystic
ovarian disease. So too, natural family planning teachers should be knowledgeable of normal
parameters so they are able to counsel their clients and alert them to what is abnormal or irregular.
Most studies conducted on the parameters of the menstrual cycle have included women with
abnormal menstrual cycles. Researchers from the University of New Mexico recently conducted a
study with only healthy women participants with non‐hormonal contraceptive menstrual cycles (L.A.
Cole, D.G. Ladner, and F.W. Byrn, “The Normal Variabilities of the Menstrual Cycle,” Fertility and
Sterility 91 [2009]: 522–527). These researchers also eliminated any menstrual cycles that were
abnormal from their calculation, i.e., menstrual cycles that were longer than 40 days. The purpose of
their study was to define the normative statistical parameters of the menstrual cycle, i.e., the length of
the follicular, ovulatory, and luteal phases, as well as the timing of implantation.
The participants for this study were 184 healthy women volunteers between the ages of 18–36 years.
Of these 184 participants, 17 were eliminated due to unusual cycle lengths or abnormal hormonal
levels. The participants had their daily urine collected for laboratory determinations of the peak
reading in LH and hCG levels. The length of the follicular phase of the menstrual cycle was defined as
the first day of menses until and including the day of the highest LH reading. The participants produced
408 normal non‐contraceptive menstrual cycles and 111 menstrual cycles that ended in a pregnancy.
The mean, standard deviation (SD), and the 95% confident interval of the statistical parameters of the
menstrual cycle, including total length, follicular phase length, ovulation phase, luteal phase, and day
of implantation as determined in this study are shown in table 1. The day of implantation was
determined from the 111 cycles that resulted in a pregnancy. The first detectable hCG reading was
considered the day of implantation. The range of the 95% confident interval (CI) can be considered the
ranges of normality. The estimated range of the day of implantation could also be interpreted as 5–14
days after the estimated day of ovulation. The finding that implantation can occur as early as day 4

after the day of ovulation is different than has been previously reported in the literature. The authors
concluded that the results provided by this study could be used as guidelines for differentiating normal
and problem menstrual cycles.
Comments: The results from this study can be used as normative parameters of the menstrual cycle.
When women have menstrual cycles outside of these lengths, the health professional, NFP provider, or
the individual woman should have some concern. Only women who have been tracking the length and
the estimated day of ovulation with some type of NFP method would have knowledge of these
parameters.

Follicular Growth during Lactational Amenorrhea Found to Be Greater than During
Normal Ovulatory Menstrual Cycle
Lactational amenorrhea (LA) is considered to be a time of ovarian quiescence due to the suppression of
ovarian hormones by the suckling mechanism that produces prolactin. Included in this quiescent
period are not only low levels of estradial and progesterone but also follicular growth. It is thought that
elevated levels of prolactin make follicles less responsive to the actions of FSH and LH. However, very
little is known about the biological mechanisms that take place during LA and the annovulation that is
associated with breastfeeding. Therefore, researchers from Chile and Argentina decided to conduct a
longitudinal study of LA in order to describe the steroidal and follicular dynamics that occur during
breastfeeding and the subsequent ovulatory menstrual cycles (.V. Velasquez, R.V. Trigo, S. Creus, S.
Campo, and H.B. Croxatto, “Pituitary‐Ovarian Axis during Lactational Amenorrhoea. I. Longitudinal
Assessment of Follicular Growth, Gonadotrophins, Sex Steroid and Inhibin Levels before and after
Recovery of Menstrual Cyclicity,” Human Reproduction 21 [2006]: 909–915).
The participants for this study were 22 healthy nursing mothers (between the ages of 18–23) that were
accessed in a maternity ward within 2 days after a normal vaginal singleton delivery. All of these
women were instructed to (and agreed to) exclusively breast‐feed their baby for the first 6 months
post‐partum. At the 60th day post‐partum these women had ultrasound exams of their ovaries and
blood samples taken twice a week for 4 consecutive weeks. When their menstrual cycles resumed,
vaginal ultrasound examinations and blood samples were drawn on days 1–4 (which was labeled the
early follicular phase, EFP) and days 7–10 (which was labeled the mid follicular phase, MFP) of the
second and third menstrual cycle post‐partum. The blood samples were assayed for FSH, LH, polactin,
estradiol, progesterone, inhibin A, inhibin B, and Pro‐alpha C levels. Of the 22 participants, 10 entered
and completed the study.
The results showed that the number and diameter of the follicles were significantly greater during LA
compared to the EFP or the MFP. Estradiol levels were similar during LA, EFP, and MFP. In comparison
to the EFP and the MFP phases of the menstrual cycle, LA is associated with higher prolactin levels,
normal or slightly elevated steroidal gonadotrophins (LH and FSH), and increased number and size of
follicles, without an increase in estradiol, inhibin B, and Pro‐alpha C. The authors concluded that during
LA there is a profound dissociation between follicular growth and follicular endocrine activity.
Comments: The more that is learned about the mechanisms of how breastfeeding suppresses ovarian
activity, the more likely it will be to provide better instructions for monitoring fertility during this
transition from amenorrhea to ovulatory menstrual cycles. One criticism of this study is that the MFP

was actually in the later stages of the follicular phase. In this study the MFP was days 7–10, but, there
is evidence that ovulation is delayed in the first 3 or more post‐partum menstrual cycles. If the authors
measured the follicular sizes from days 10–16, they likely would have found they were greater.

Web‐Based Patient Education Intervention Found Beneficial for Women Experiencing
Infertility
The medical and technical aspects of infertility tests and treatments can be psychologically challenging
for couples with infertility problems. There are few support systems to help patients cope with the
psychological aspects of infertility treatment. In today's world, many people pursue medical
information and advice from online Internet‐based programs. However, there have been few studies
that have investigated the effectiveness of these online programs. Therefore, infertility researchers
sought to develop and test the effectiveness of a brief Web‐based education and support system for
female infertility patients (T.M. Cousineauy, T.C. Green, E. Corsini, A. Seibring, M.T. Showstack, L.
Applegarth, M. Davidson, and M. Perloe, “Online Psychoeducational Support for Infertile Women: A
Randomized Controlled Trial,” Human Reproduction 23 (2008): 554–566). They built an online program
called the Infertility Source program that included information on fertility, reproductive anatomy and
physiology, cognitive behavioral skills, and stress management techniques. They hypothesized that
those women who were exposed to an online Infertility Source program would demonstrate a
reduction in infertility‐related stress and an improvement in infertility self‐efficacy.
The researchers utilized a randomized control trial design in which 190 women, who were at least 21
years old with a diagnosis of infertility, were randomized into a group that was exposed to the online
Infertility Source program and a group that served as a control and were told that they were in a study
to determine how couples cope with infertility. The outcomes that were assessed were infertility
distress, infertility self‐efficacy, decisional conflict, marital cohesion, and coping style. The researchers
found that those women who were exposed to the online Infertility Source program had significant
improvement in the area of social concerns related to infertility and felt more informed about medical
decisions in which they were involved. Those women who were exposed to the Web site for 60
minutes or more experienced a significant decrease in global stress and increased self‐efficacy. The
researchers concluded that an online infertility support program can have beneficial psychological
effects and can be a cost effective resource for fertility practices.
Comments: The participants in this study received one hundred dollars for participating and filling out
the study questionnaires. Having a financial incentive could be a con‐founder for the results of the
study in that without the incentive we do not know how effective the Web site is or how many women
would use it. This study also points out the importance of being exposed to the intervention, i.e., the
information on the Web site. The study showed that the more exposure to the Web site, the better the
outcome. Web site information for fertility and infertility are convenient and accessible. This was the
first study to determine the efficacy of an online infertility support and educational system. Similar
studies are needed to assess the benefits of online charting and information for natural family planning
purposes.

Quality of Infertility Information on the World Wide Web Rated Poor
The Internet has increasingly become the source of information for people seeking health information
and advice. A recent study showed that up to 80% of people in the United Kingdom (UK) who are
connected to the Internet have used the World Wide Web (WWW) as a source of health information
(J.V. Marriott, P. Stec, T. El‐Toukhy, Y. Khalaf, P. Braude, and A. Coomarasamy, “Infertility Information
on the World Wide Web: A Cross‐Sectional Survey of Quality of Infertility Information on the Internet
in the UK,” Human Reproduction 23 [2008]: 1520–1525). The use of the Internet as a source of
information includes people seeking information on infertility. There are many Web sites dedicated to
information on infertility. However, there has never been a study to assess the quality of these web
sites. Therefore, researchers from the UK conducted a study to determine the quality of information
on infertility available on the Web.
The researchers performed a Google search with the word “infertility” and then assessed and classified
the first 107 usable and relevant Web sites that were produced by the search. The Web sites were
classified as either: 1) National Health Service (NHS) managed and funded, 2) private assisted‐
reproductive‐technology (ART) clinic Web site, 3) non‐ART treatment providing, 4) commercial
information providing, 5) non‐profit making information site, and 6) patient forum sites. The quality of
the Web site was assessed by 3 key features: credibility, accuracy, and navigability. Credibility was
assessed by 6 criteria, accuracy by 3, and navigability by 6, for a total of 15 criteria that were either
present or not (see criteria listed below). The researchers summed and averaged the criteria for all 107
sites. Therefore, the maximum score for credibility and navigability was 642 and for accuracy 321.
The researchers found that the total scores for all types of infertility web sites were low. The lowest
rated feature was accuracy in which a total of only 50 points out of 321 (16%) were tallied. The highest
rated feature was navigability with 60% or 387 points out of 642, and then credibility with 275 of the
642 points (43%) tallied. The highest rated sub‐criteria was having fully functional internal and external
links with 90% of the sites receiving a score. The NHS ART clinic sites rated higher overall than the
private ART clinic sites and the commercial and non‐profit information sites. The authors concluded
that the quality of Internet information sources for infertility is variable, but generally poor.
Comment: The authors also recommended that individual clinicians rate and assess the quality of Web
sites before recommending them to their patients. The same recommendation should be made for
natural‐family‐planning and fertility‐awareness teachers. The criteria for each of the three key Web
features are listed below for use in assessment:
Credibility:
1) Authorship—names of authors are clearly displayed
2) Currency—either date of last amended or copyright date
3) Legal disclaimer—legal statement disclaiming responsibility for the information presented or
what users choose to do with the information
4) Review process—information provided about a review board
5) Funding or sponsorship—information concerning the source of the organization funding
6) Absence of advertising or financial incentives

Accuracy:
1) Claims supported by valid evidence or professional body guidelines
2) Clearly defined success rates
3) Display of accurate references
Navigability:
1)
2)
3)
4)
5)
6)

Functional internal and external links
Viewer is not directed to unintended sites
Active feedback mechanism with e‐mail based contact
Frequently asked question (FAQ) page
A site map
Internal search engine

Discontinuation Rates of Fertility‐Awareness Methods Found to Be High Compared to
Other Family Planning Methods
Women of child‐bearing years often discontinue methods of contraception for many reasons (other
than seeking to achieve pregnancy) and switch to another method that they believe will fit their
lifestyle better, be more effective, have less side effects, or maybe be easier to use. The transition from
one method to another, however, is a time when women often become unintentionally pregnant.
Researchers from the Guttmacher Institute in collaboration with Professor James Trussell at Princeton
University recently analyzed data from the 2002 National Survey of Family Growth (NSFG) to
determine the discontinuation rates of the Pill, injectable, male condom, withdrawal, and fertility‐
awareness based methods of family planning (B. Vaughan, J. Trussell, K. Kost, S. Singh, and R. Jones,
“Discontinuation and Resumption of Contraception Use: Results from the 2002 National Survey of
Family Growth. Contraception 78 [2008]: 271–283). They analyzed the 2002 NSFG data and adjusted
the results based on the underreporting of abortion.
The 2002 NSFG is a population survey conducted on a periodic basis by the National Center for Health
Statistics. The 2002 NSFG involved 7,643 women between the ages of 15–44. The participants in the
NSFG were interviewed in person by inputting data into a laptop computer. The researchers discovered
that the discontinuation rate for method‐related reasons within the first year was as follows, 57% for
the male condom, 54% for withdrawal, 53% for fertility‐awareness based methods, 44% for injectables,
and the lowest was 33% for the Pill. The researchers also found that although these women abandon a
method of contraception, 72% will resume another method of contraception within the initial month
of exposure. The researchers did not analyze the reasons for the discontinuation of fertility‐awareness‐
based methods. The researchers did find for all methods that teenagers and those cohabitating are
more likely to abandon contraceptive methods compared to non‐teenage married women.
Comments: Although the discontinuation rates are fairly high with fertility‐awareness‐based methods
(according to the NSFG 2002 data), one should keep in mind that included in these methods are self‐

devised calendar methods. If the researchers analyzed only those women who were married and were
using a more modern method of NFP, such as temperature or cervical mucus methods, they most likely
would find a much lower discontinuation rate. Furthermore, in a recent study involving the same data
from the 2002 NSFG, researchers found that there was a very low discontinuation rate with fertility‐
awareness‐based methods due to dissatisfaction, i.e., only 14.6%. for ever‐users of fertility‐awareness
methods, compared with much higher rates for the diaphragm or cervical cap (52%), long acting
hormonal methods (42%) or oral contraceptives (29%) (C. Moreau, K. Cleland, and J. Trussell,
“Contraceptive Discontinuation Attributed to Method Dissatisfaction in the United States,
Contraception 76 [2007]: 267–272). The failure of the authors to include a discussion in their paper of
the relatively low discontinuation rate due to dissatisfaction with fertility‐awareness‐based methods
may indicate a bias against these methods by the authors.

Increased Breast Tissue Proliferation Found with Combined Oral Contraceptives
There are many health benefits for women taking combined oral contraceptives (COCs), but there are
health risks as well, such as thrombosis, that could lead to a stroke or myocardial infarction. Another
health risk is breast cancer, in particular for young women who are on COCs for a long time before
discontinuing or becoming pregnant. Researchers from Stanford University and the Federal University
of Brazil recently conducted a study to investigate further the possible influence of COCs on breast
tissue (i.e., mammary epithelial cells) during one cycle of use (D.G. Narvaiza, A.H. Navarrete, R. Falzoni,
C.M. Maier, and A.C.P. Nazario, “Effect of Combined Oral Contraceptives on Breast Epithelial
Proliferation in Young Women, Breast Journal 14 [2008]: 460–465). The proliferation of normal breast
epithelium is most extensive during the natural luteal phase of the menstrual cycle.
The researchers enrolled 82 volunteer patients who were undergoing excision of a fibroadenoma. The
82 women, who were between the ages of 14–36 with normal length menstrual cycles and who never
used COCs, were randomized into either a treatment group that received one cycle of COCs (containing
ethinyl estradiol and levonorgestrel) or a control group that had a normal spontaneous menstrual
cycle. Serum progesterone levels were taken to document suppression of endogenous progesterone
secretions with the COC participants and to determine the phases of the menstrual cycle with the
control group members. All participants had mammary tissue biopsied throughout the menstrual cycle.
There were no statistical differences in age of menarche, number of pregnancies, parity, and
lactational history.
The researchers found a greater proliferation index in the COC group compared to the normal cycling
control. They also found greater proliferation in the COC cycles during the first week of the pseudo‐
menstrual cycle. The researchers speculated that this alteration in the pattern of proliferative activity
may explain some of the increased risk of breast cancer associated with COC use.
Comment: Epithelial cell proliferation in normal (non‐COC) menstrual cycle occurs in the luteal phase,
when both estrogen and progesterone levels are high. This suggests that there is a synergistic
mechanism. The fact that this takes place early in the menstrual cycle and continues throughout the
use of COCs might explain some of the possible carcinogenic effects of COCs. The researchers made it
clear that this study needs to be replicated in order to validate these findings.

Induced Abortion Reported Not to Be Associated with Breast‐Cancer Risk
Past retrospective and case‐controlled studies have shown an association between induced abortion
and the risk of breast cancer. Authors of these studies have speculated that the increase was due to a
number of reasons, i.e., the loss of the protective effect of pregnancy against breast cancer, the
stimulation of the growing breast tissue by pregnancy hormones, and the stopping of breast‐cell
differentiation at the time of abortion. With a full‐term pregnancy, breast tissue is allowed to
differentiate and mature, and is not, therefore, susceptible to carcinogenic effects. Large recent
prospective studies have not found the association between abortion and breast cancer and have not
supported these hypothetical mechanisms.
Researchers recently conducted a large prospective cohort study to see if an association existed
between early induced abortions and breast cancer (K.D. Henderson, J. Sullivan‐Halley, P. Reynolds, P.
Horn‐Ross, C.A. Clarke, E.T. Chang, S. Nuehausen, G. Ursin, and L. Bernstein, “Incomplete Pregnancy Is
Not Associated with Breast Cancer Risk: the California Teachers Study,” Contraception 77 [2008]: 391–
396). They also investigated the association between miscarriage and breast cancer. The study
population consisted of women who responded to the California Teachers Study (CTS). The CTS
involved 133,479 current, recent, and retired female public‐school teachers and administrators who
completed the CTS survey. The CTS survey included items about pregnancy, pregnancy outcomes,
abortion, and miscarriage. The final number of women for the study was 109,893 due to a reduction of
participants who did not meet the criteria for the study. The number of incident breast‐cancer cases
reported by this group and validated by the California cancer registry was 3,324. Of these participants,
approximately 19% reported miscarriages, and 19% reported abortions. However, the results did not
show any significant association between breast cancer and induced abortion, nor did it show an
association between miscarriage and breast cancer when compared with nulliparous or parous
women. The authors concluded that this study provided strong evidence that there is no relationship
between any means of incomplete pregnancy and breast‐cancer risk among nulliparous and parous
women. The study results are supported by two other recent large prospective cohort studies, i.e., one
involved the 105,716 women in the Nurses’ Health Study and the other 267,361 women recruited from
20 centers and 9 European countries (K.B. Michels, F. Xue, G.A. Colditz, and W.C. Willett, “Induced and
Spontaneous Abortion and Incidence of Breast Cancer among Young Women,” Archives of Internal
Medicine 167 (2007): 814–820; G.K. Reeves, S.W. Kan, T. Key, et. al., “Breast Cancer Risk in Relation to
Abortion: Results from the EPIC Study,” International Journal of Cancer 119 [2006]: 1741–1745). Both
studies concluded that neither induced abortion nor spontaneous abortion was associated with the
incidence of breast cancer. However, the European study found a slightly higher risk among those with
2 or more spontaneous abortions.
Comments: Although there was some speculation that the participants underreport‐ed abortion, as is
often found in studies with self‐reporting of abortion, the rate of abortions reflects the number of
abortions reported in a well‐educated middle‐class population. As a health professional or NFP
teacher, although there is conflicting evidence regarding the link between abortion and breast cancer,
it does not appear to be appropriate to suggest that there is a relationship between abortion and
breast cancer to women at this time. For a different perspective, see Angela Lanfranchi, “Normal
Breast Physiology: The Reasons Hormonal Contraceptives and Induced Abortion Increase Breast‐Cancer
Risk,” in this issue.

Women Using Hormonal Contraceptives Report More Negative Well‐Being Compared to
Women with Natural Hormonal Menstrual Cycles
Little research has been conducted to determine the effects of hormonal contraception, and, in
particular, injectable hormonal contraception (i.e., Depo‐Provera), on the physical and psychological
well‐being of women. Injectable contraceptives, unlike oral hormonal contraception and natural
menstrual cycles, do not have the cyclical variations of the hormones estrogen and progesterone.
Therefore, women on the injectable contraceptive probably would not vary in their well‐being as
would women with variations in hormonal profiles. Researchers from the University of Hawaii
conducted a study to determine if there were differences in well‐being of women who used Depro‐
Provera injectable contraceptives compared to women with natural hormonal menstrual cycles, and
with women on cyclical hormonal oral contraceptives (S.G. Brown, L.A. Morrison, L.M. Larkspur, A.L.
March, and N. Nicolaisen, “Well‐Being, Sleep, Exercise Patterns, and the Menstrual Cycle: A
Comparison of Natural Hormones, Oral Contraceptives and Depo‐Provera,” Women & Health 47
[2008]: 105–121).
The participants for this study were 36 women, selected by convenience with flyers and short
announcements at university events and courses. Most of the women participants were students from
the researcher's university. Twelve of the women were using DepoProvera, 12 were using oral
hormonal contraceptives, and 12 were using condoms or coitus‐interruptus during intercourse and,
thus, had synthetic hormone‐free menstrual cycles. All of the participants were asked to complete a
well‐being questionnaire and monitor their sleep and exercise patterns on a daily basis for 3 menstrual
cycles (or for three 28 day cycles for the women on Depro‐Provera). The 36 women produced 108
menstrual cycles of data. The participants ranged in age from 18–36 years.
The researchers found that the women participants in the natural‐hormone group reported
significantly less negative well‐being compared to women in the hormonal‐contraceptive groups (i.e.,
the oral and injectable hormonal contraceptive participants). Furthermore, the women with natural,
hormonal menstrual cycles and the women on cyclical, oral‐hormonal contraception reported more
positive well‐being mid‐cycle that was correlated with increased sleep. This variation in well‐being was
not reported with the DepoProvera group of women. The authors concluded that the use of
DepoProvera interfered with the natural relationships between sleep, well‐being, and cycle phases.
Comments: The results of this study must be taken with reservations, since the participants were
selected by convenience and were not randomized into the three groups. Therefore, there could be
other reasons for the differences in well‐being found between the three groups. Furthermore, there
were not enough participants in each group to have enough statistical power to elicit statistical
differences on many of the variables. It was interesting that negative well‐being (as measured by a
multiple‐item questionnaire that is utilized to diagnose premenstrual dysphoric disorder or PMS) was
less among the natural, hormonal menstrual cycle group, since hormonal contraceptives are often
used to treat that syndrome. It would be good to see a replication of this study with non‐sexually
active women in the natural hormonal group, since sexual relationships could be a confounding
variable.

Under the Microscope
Breast‐Feeding and Early Pregnancy Loss
William Saletan, a political columnist for the online Web site Slate (www.slate.com), recently wrote a
letter to the secretary of the U.S. Department of Health and Human Services (Michael O. Leavitt)
concerning the administration's proposal to eliminate financial aid to health‐care institutions that
violate the right of health‐care providers who, for reasons of conscience, refuse to participate in
abortion and the prescribing of potentially abortifacient contraceptive methods.1 Throughout his
letter, Saletan ostensibly supported the administration's proposal. Saletan stated in the letter that the
government should not only protect health‐care providers who refuse to participate in abortion, but
also provide protection for employees that are involved in other potentially abortifacient activities, i.e.,
those employees that promote and teach breastfeeding, those who are involved with the manufacture
or selling of coffee in any capacity, and those who are involved with promoting exercise. He provided
studies and evidence that all three of these activities are potentially abortifacient. Obviously his
proposed extension of the right to refusal for conscience purposes by health professionals to
breastfeeding, coffee, and exercise was full of sarcasm and is a type of reductio ad absurdum.
The study he cited for evidence that breastfeeding can act as an abortifacient was conducted by a
group of researchers (including NFP professional nurse teachers) at the Pontifical Catholic University of
Chile.2 The study involved a comparison of 49 fully breastfeeding post‐partum women and 25 non‐
nursing women who had regular menstrual cycles. The researchers measured plasma estradiol (E) and
progesterone (P) levels twice a week up to the second postpartum menses. They found that in the first
post‐partum menstrual cycles the luteal phase for the breastfeeding women was on average 9.2 days
(SD=0.5) in length and for the non‐nursing women 13.3 days (SD = 0.4). Since about one‐fourth of the
non‐nursing women became pregnant during the study time period, but only 7% of the breastfeeding
women, the authors speculated that the reason for such a difference was due to interference with
implantation of the embryo associated with luteal phase defects.
Another study conducted by researchers from Johns Hopkins University concluded the same thing.3
They monitored 60 breastfeeding women from Baltimore and 41 from Manila (Philippines) by having
them provide urine samples for E, P, LH, and human chorionic gonadotropin (HCG) on a daily basis.
They found that 41% of the first ovulation cycles had luteal phase defects. They also found a 6%
pregnancy rate in the first cycle after the first menses. In another study, an Australian research group
analyzed the P levels of 89 breastfeeding women by daily salivary samples.4 They defined a deficient
luteal phase when P levels were less than 40 pg/mL and a short luteal phase as a period of 11 days or
less from ovulation to menstruation. They found only 32% of the women had adequate luteal phases
after their first menstruation. Another earlier study by an Australian group found with 55 post‐partum
breastfeeding women that, after the first menses, 40% had anovulatory ovarian activity, 25%
experienced ovulation but with short luteal phases, and 16% had normal ovulations with deficient
luteal phases, i.e., luteal‐phase lengths less than 11 days.5
It is clear from the evidence provided by the above studies that there are many (25–40%) deficient
(hormonally) and short (by days) luteal phases in the first post‐partum menstrual cycle. There also is
evidence that the pregnancy rate of women during the first post‐partum menstrual cycle is much lower
than expected in normal cycling women, i.e., 6–7% compared to 25%. One possible explanation is that
luteal phase defects cause a failure in implantation of the embryo. However, all of this evidence is

indirect. None of these studies compared the pregnancy rate or the luteal phase parameters with post‐
partum non‐breastfeeding women. An earlier study from Ireland monitored the daily salivary E and P
levels of 30 post‐partum breastfeeding and non‐breastfeeding women.6 As expected, they found that
the return of first menstruation among the 20 breastfeeding women was much longer than the non‐
breastfeeding women, i.e., a mean of 127 days compared to 57 days. The researchers also found that
44% of the breastfeeding women and 40% of the non‐breastfeeding women had abnormal luteal
phases. There was no evidence for differences in the amount of luteal phase defects in the first
menstrual cycle post‐partum among the breastfeeding and non‐breastfeeding women. In both groups
50–56% of the first cycles were anovulatory. Therefore, the luteal phase deficiency might not be due to
breastfeeding but rather the hormonal readjustment that occurs during the post‐partum time frame.
Furthermore, the decreased pregnancy rates for post‐partum breastfeeding women might largely be
due to anovulatory menstrual cycles, i.e., menstrual cycles with no chance of fertilization.
Evidence from other recent studies also raises some questions about whether breastfeeding might
cause a disruption in implantation due to luteal phase defects. A study, reviewed earlier in this
publication, showed that among normal menstrual cycles, implantation (as determined by HCG levels)
can occur as early as the fourth day post‐partum.7 The researchers gave a normal range of 5–14 days
for the luteal phase. The 11‐day post‐partum mean reported for breastfeeding cycles (i.e., as reported
in the above studies) fit well into this range. O. Bukulmez and A. Arici questioned the wisdom of
diagnosing a luteal phase defect and preferred to view it as an ovulatory defect.8 The authors point out
that luteal phase defects are poorly defined and often diagnosed in women with proven fertility.
Even if breastfeeding caused luteal‐phase deficiencies and impaired the implantation of human
embryos, it is not the moral equivalent of the use of hormonal contraception to prevent pregnancy.
Breast‐feeding is done primarily for the intent of providing adequate nutrition for the neonate. Breast‐
feeding is natural and healthful for both the baby and the mother and is recommended, for at least
one year, by the American Pediatric Association. Breast‐feeding is better than artificial nutrition.
Breast‐feeding is a good and natural act for the purpose of a good end that also (at times) might result
in the unintended death of embryos (although direct evidence for such an effect is lacking).
Hormonal contraception, on the other hand, is used for the purpose of suppressing a natural process
(i.e., fertility) for the intended effect of avoiding pregnancy and having intercourse without any
consequences. Even though breastfeeding could be viewed as an external hormonally suppressing
process, the child's need for nutrition is not. The ingestion of steroidal hormones frustrates the natural
fertility of the woman. Furthermore, the suppressing effect of breastfeeding diminishes as the baby
grows and starts to utilize solid foods and liquids. The use of and need for hormonal contraception
continues throughout the entire reproductive life of the woman.
A secondary reason for using hormonal contraception might be to enhance one's health or to treat a
disease process. The hormones, however, might just as easily cause health problems, such as increased
risk for blood clots, stroke, heart attack and breast cancer. Furthermore, the use of hormonal
contraception prevents the integration of fertility within the marital act of intercourse. The intention of
hormonal contraception is to frustrate this integration. Hormonal contraception is not a holistic but
rather a non‐integrative externally controlled act. Whereas breastfeeding diminishes fertility,
especially in the first 6 months of use, the infertility that is established is not permanent and is more
like the infertility that one experiences after menopause, i.e., it is a natural infertility. But probably the

biggest difference between hormonal contraception and breastfeeding is that contraception takes
fertility and procreation out of the picture altogether. It makes the contracepting individual susceptible
to being an object of sex rather than a person deserving of love and acceptance of who they are—not
who they are minus their fertility.
To morally equate breastfeeding with hormonal contraception in causing early pregnancy loss is
absurd. Saying that breastfeeding is a cause of early pregnancy loss and that health professionals
should inform women of this process is tantamount to saying that we should warn women against
living a virtuous life. No more would a health professional warn a woman about driving a car because
she might get into an accident and kill a pedestrian. As Miller points out in his essay on contraception,
contraception is contrary to reason itself, and so it is immoral.9 Breast‐feeding is not contrary to reason
and not contrary to the expectation that it is a good for a woman to nourish her child through
breastfeeding. Saletan, in his opinion article, is trying to argue that it is absurd for health professionals
to refuse to prescribe both the use of contraception and breastfeeding. However, his parallel
absurdities do not logically work.
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